Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Frontiers in Immunology

Topics

Biology

Biochemistry

Engineering

Medicine

Immunology

Show all topics

DOI

10.3389/fimmu.2021.746021

License

CC-BY

Other Formats

PDF